SLeX could influence prostate cancer progression through numerous mechanisms, including binding to E-selectin, the evasion of Natural Killer (NK) cell immunity, and the promotion of bone metastasis [52,54,55,56]. The gene discussed is SELE; the disease is prostate cancer.